RxDoctor Payments Data

Thomas Eagan, DO

Obstetrics & Gynecology · Grants Pass, ORNPI 1578713673

Payments from drug & device makers

What this record shows

This record is dominated by education: $7,085 of the $10,742 with a category attached, or 66.0%. Intuitive Surgical accounts for 91.6% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $5,223, more than ten times the $42 reported in 2019. Among obstetrics & gynecology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,742in general payments, 2019–2025

Across 61 payments — averaging $176.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$10K
  • AbbVie$319
  • Coloplast$219
  • Hologic Sales And Service, LLC$90
  • Astellas Pharma US Inc$67
  • Biogen$57
  • plus $151 from 6 others

What the payments were for

  • Travel & lodging$2,37422%
  • Food & beverage$1,28312%
  • Education$7,08566%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,742 in reported general payments places this provider in the 95th percentile of 480 obstetrics & gynecology providers in Oregon.

See all obstetrics & gynecology providers in Oregon

Medicare billing

Part B allowed, 2024
$53,685
Medicare patients
124
Services billed
384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron46$43,152
Estradiol119$4,312
ProgesteroneProgesterone, Micronized90$3,686
PremarinEstrogens, Conjugated14$3,432
DottiEstradiol12$2,274
Oxybutynin Chloride ErOxybutynin Chloride29$1,341
Solifenacin Succinate17$1,290
Estradiol (Once Weekly)Estradiol13$1,202
Clobetasol Propionate15$805
Acyclovir11$447
EstaryllaNorgestimate-Ethinyl Estradiol13$354
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip16$329
ValacyclovirValacyclovir Hcl11$219
Alendronate Sodium24$214
Ondansetron OdtOndansetron25$152

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$67$43,15246 claims
PfizerPremarin$52$3,43214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 480 obstetrics & gynecology providers in Oregon.

Other obstetrics & gynecology in Grants Pass

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →